Clinical Trial Update: Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and immunogenicity of co-administering the HPV vaccine Cervarix with other vaccines in healthy female subjects; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-08-23